Chief Financial Officer · Spyre Therapeutics, Inc. · Common Stock
Side
SELL
Value
$436K
Shares
5,000
Price
$87.12
Executed
Jun 25, 2026
Disclosed
Jun 26, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jun 25 executedJun 26, 2026 disclosed
SYRE · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Burrows Scott L filed this Form 4 reporting a open-market sale of SYRE on Jun 25, 2026. It became public on Jun 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Burrows Scott Lcik:0001853327
Issuer
Spyre Therapeutics, Inc.cik:0001636282
Revision history · 0
No field has changed since this record was first ingested.
